FDA Approves Beyfortus for Use in Infants With RSV : vimarsa

Beyfortus, which can help prevent respiratory syncytial virus (RSV) in infants and toddlers, was approved by the FDA on July 17.

Related Keywords

United States , John Farley , Office Of Infectious Diseases , Infectious Diseases , Drug Evaluation , Rsv , Beyfortus , Infants , Prevent ,